Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.



The majority of the tests offered by the laboratories are accredited to iso15189:2012:

Tests currently provided outside the UKAS schedule of accreditation:

  • Biochemical service to measure Pyruvate Dehydrogenase (PDH) enzyme activity in cultured fibroblasts (due to the specialist nature of this test)
  • Myeloid disorders revised gene panel / TP53 lymphoid malignancies (pending Extension to Scope)
  • DNA extraction by Maxwell instrument in Oxford Molecular Haematology Laboratory (pending Extension to Scope)

Quality control

Oxford Genetics Laboratories participate in the Genomics Quality Assessment Schemes or other UK NEQAS schemes for each aspect of our service, as appropriate.

The laboratory validates and verifies all tests prior to implementation and incorporates internal quality control measures within its procedures.

Clinical advice

Clinical advice is available to clinicians on all aspects of service provision including selecting appropriate tests, sample requirements, testing pathways, interpretation of results and professional discussion of individual cases.

For all enquiries, please contact us and we will direct you to the appropriate person.


We welcome feedback from our users and undertake regular surveys.